Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease.

Pathogenic variants in the glucocerebrosidase gene (GBA) encoding the enzyme deficient in Gaucher's disease (GD) are associated with Parkinson's disease (PD). To investigate the sequence variants, their association with PD and the related phenotypes in a large cohort of European, mostly French, patients and controls, we sequenced all exons of GBA in 786 PD patients from 525 unrelated multiplex families, 605 patients with apparently sporadic PD and 391 ethnically matched controls. GBA mutations were significantly more frequent (odds ratio=6.98, 95% confidence interval 2.54-19.21; P=0.00002) in the PD patients (76/1130=6.7%) than in controls (4/391=1.0%) and in patients with family histories of PD (8.4%) than in isolated cases (5.3%). Twenty-eight different mutations were identified in patient and control groups, including seven novel variants. N370S and L444P accounted for 70% of all mutant alleles in the patient group. PD patients with GBA mutations more frequently had bradykinesia as the presenting symptom and levodopa-induced dyskinesias. The phenotype was similar in patients with one, two or complex GBA mutations, although the two patients with c.1263del+RecTL and N370S/RecΔ55 mutations had signs of GD. Segregation analyses in 21 multiplex families showed that 17% of the affected relatives did not carry GBA mutations found in the given family, indicating heterogeneity of the aetiology, but 46% of the unaffected relatives were GBA mutation carriers. These genotype and clinical analyses on the largest homogeneous sample of European patients studied to date confirmed that GBA mutations are the most common genetic risk factor for PD, particularly in familial forms.

[1]  C. Paisán-Ruiz,et al.  Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece , 2009, Neuroscience Letters.

[2]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[3]  R. Desnick,et al.  Non-pseudogene-derived complex acid beta-glucosidase mutations causing mild type 1 and severe type 2 gaucher disease. , 1999, The Journal of clinical investigation.

[4]  E. Sidransky,et al.  Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease. , 2007, Molecular genetics and metabolism.

[5]  G. Pastores,et al.  Identification and characterization of a novel mutation c.1090G>T (G325W) and nine common mutant alleles leading to Gaucher disease in Spanish patients. , 2001, Blood cells, molecules & diseases.

[6]  E. Beutler,et al.  Hematologically important mutations: Gaucher disease. , 2005, Blood cells, molecules & diseases.

[7]  E. Sobreira,et al.  Detection of 12 new mutations in Gaucher disease Brazilian patients. , 2006, Blood cells, molecules & diseases.

[8]  F. Hu,et al.  Association of the glucocerebrosidase N370S allele with Parkinson’s disease in two separate Chinese Han populations of mainland China , 2010, European journal of neurology.

[9]  P. S. St George-Hyslop,et al.  Analysis of the glucocerebrosidase gene in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[10]  Yusuke Nakamura,et al.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.

[11]  D. Elstein,et al.  The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. , 2005, The New England journal of medicine.

[12]  A. Quattrone,et al.  Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy , 2008, Movement disorders : official journal of the Movement Disorder Society.

[13]  E. Beutler,et al.  Hematologically important mutations , 2005 .

[14]  J. Aharon-Peretz,et al.  Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. , 2004, The New England journal of medicine.

[15]  A. Brice,et al.  Parkinson's disease: from monogenic forms to genetic susceptibility factors. , 2009, Human molecular genetics.

[16]  E. Sidransky,et al.  Glucocerebrosidase mutations in subjects with parkinsonism. , 2004, Molecular genetics and metabolism.

[17]  A. Singleton,et al.  Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal , 2009, Neurobiology of Aging.

[18]  K. Marder,et al.  Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease , 2007, Neurology.

[19]  Daniel Grinberg,et al.  Promising results of the chaperone effect caused by imino sugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease. , 2009, Blood cells, molecules & diseases.

[20]  A. Singleton,et al.  Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. , 2009, Brain : a journal of neurology.

[21]  Yi Zhao,et al.  Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients. , 2007, Archives of neurology.

[22]  M. Farrer,et al.  Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population , 2006, Neurology.

[23]  P. Pollak,et al.  Progressive encephalomyelitis with rigidity and myoclonus: Resolution after thymectomy , 2011, Neurology.

[24]  Yih-Ru Wu,et al.  Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[25]  Nir Giladi,et al.  Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset , 2008, Neurology.

[26]  E. Sidransky,et al.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA) , 2008, Human mutation.

[27]  T. Foroud,et al.  Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset , 2009, Neurology.

[28]  K. Doheny,et al.  Genomewide association study for susceptibility genes contributing to familial Parkinson disease , 2009, Human Genetics.

[29]  M. Pocovi,et al.  Detection of three rare (G377S, T134P and 1451delAC), and two novel mutations (G195W and Rec[1263del55;1342G>C] in Spanish Gaucher disease patients , 1999, Human mutation.

[30]  Nir Giladi,et al.  Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations. , 2009, Brain : a journal of neurology.

[31]  A. Toyoda,et al.  Mutations for Gaucher disease confer high susceptibility to Parkinson disease. , 2009, Archives of neurology.

[32]  J. Stockman.  Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease , 2011 .

[33]  Y. Agid,et al.  G2019S LRRK2 mutation in French and North African families with Parkinson's disease , 2005, Annals of neurology.

[34]  Tatiana Foroud,et al.  Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease , 2005, The Lancet.